11. Other operating expenses
| Other Operating Expenses | [Table 4.30] | |
|---|---|---|
| 2008 | 2009 | |
| € million | € million | |
| Losses from sales of noncurrent assets and from divestitures | (23) | (26) |
| Write-downs of receivables | (113) | (106) |
| Expenses related to significant legal risks | (106) | (225) |
| Recognition of hedges | (193) | (212) |
| Miscellaneous operating expenses | (983) | (1,088) |
| Total | (1,418) | (1,657) |
| of which special items | (682) | (904) |
Details of special items, which almost entirely relate to significant legal risks or are included in miscellaneous operating expenses, are given in the management report in Table 3.16, on a net basis.
Information on the restructuring expenses reported there is provided in Note [26.3].
The following table provides a breakdown of the special items included in other operating expenses by the function to which they relate:
| Breakdown of Special Items by Function | [Table 4.31] | |
|---|---|---|
| 2008 | 2009 | |
| € million | € million | |
| Production-related | (220) | (305) |
| Marketing- and distribution-related | (44) | (148) |
| Research- and development-related | (135) | (37) |
| General-administration-related | (132) | (125) |
| Other | (151) | (289) |
| Total | (682) | (904) |



Overview
Notes to the Consolidated Financial Statements of the Bayer Group
Bayer Links
Investor Relations


Advanced Search



